WallStSmart
SNSE

Sensei Biotherapeutics Inc

NASDAQ: SNSE · HEALTHCARE · BIOTECHNOLOGY

$26.62
-5.94% today

Updated 2026-04-30

Market cap
$39.04M
P/E ratio
P/S ratio
EPS (TTM)
$-16.72
Dividend yield
52W range
$5 – $37
Volume
0.1M

WallStSmart proprietary scores

21
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$50.00
+87.83%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.86M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-48.81M$-34.10M$-30.16M$-21.09M$-4.72M
EPS$-16.72
Free cash flow$-39.35M$-32.20M$-24.82M$-20.47M$-3.86M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SNSE$39.04M214.33.05.05.0Avoid
LLY$789.69B7810.010.05.06.5Strong Buy
JNJ$547.64B594.79.03.36.0-41.97%Buy
ABBV$351.47B634.08.04.75.0-24.92%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Sensei Biotherapeutics Inc trades at $26.62. Our Smart Value Score of 21/100 indicates the stock is weak.

Frequently asked questions

What is Sensei Biotherapeutics Inc's stock price?
Sensei Biotherapeutics Inc (SNSE) trades at $26.62.
Is Sensei Biotherapeutics Inc overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Sensei Biotherapeutics Inc (SNSE)?
The analyst target price is $50.00, representing +87.8% upside from the current price of $26.62.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-74.00%
Beta-0.10
50D MA$30.11
200D MA$14.42
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years